Articles
Streptomycin Treatment of Pulmonary Tuberculosis
Br Med J 1948; 2 doi: https://doi.org/10.1136/bmj.2.4582.769 (Published 30 October 1948) Cite this as: Br Med J 1948;2:769
Related articles
- No related articles found.
See more
- Marburg virus: First cases in Rwanda spark international alarmBMJ October 02, 2024, 387 q2155; DOI: https://doi.org/10.1136/bmj.q2155
- Mpox is accelerating antimicrobial resistance in Africa, officials warnBMJ September 27, 2024, 386 q2124; DOI: https://doi.org/10.1136/bmj.q2124
- Politicians are failing to prepare for next pandemic, warns head of European health agencyBMJ September 26, 2024, 386 q2115; DOI: https://doi.org/10.1136/bmj.q2115
- Whooping cough: Fivefold rise in US cases spells return to pre-pandemic levelsBMJ September 26, 2024, 386 q2114; DOI: https://doi.org/10.1136/bmj.q2114
- Boy who survived life support withdrawal confirms “medicine is a science of uncertainty,” says judgeBMJ September 26, 2024, 386 q2108; DOI: https://doi.org/10.1136/bmj.q2108
Cited by...
- Reducing overweight and obesity; so how are we doing?
- Drug resistance prediction for Mycobacterium tuberculosis with reference graphs
- Drug resistance prediction for Mycobacterium tuberculosis with reference graphs
- Comparing the clinical trial characteristics of industry-funded trials and non-industry-funded trials
- The Natural History of Untreated Pulmonary Tuberculosis in Adults: A Systematic Review and Meta-Analysis
- Chemical-genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacy
- All nonadherence is equal but is some more equal than others? Tuberculosis in the digital era
- Challenges for funders in monitoring compliance with policies on clinical trials registration and reporting: analysis of funding and registry data in the UK
- Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data
- Methicillin resistant Staphylococcus aureus emerged long before the introduction of methicillin in to clinical practice
- Studying new antibiotics for multidrug resistant infections: are todays patients paying for unproved future benefits?
- Molecular Mechanisms of Intrinsic Streptomycin Resistance in Mycobacterium abscessus
- Prediction of long-term outcome subtypes in ARDS: first steps towards personalised medicine in critical care
- Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application
- De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro
- Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis
- Thorax protocol review: working with trialists to improve trial quality
- Evolution of Resistance to Continuously Increasing Streptomycin Concentrations in Populations of Escherichia coli
- Cures
- The truths we seek and the randomised trialin orthopaedic surgery
- Are clinical trials units essential for a successful trial?
- Novel drugs against tuberculosis: a clinician's perspective
- Andrew Douglas
- Oral DAV131, a Charcoal-Based Adsorbent, Inhibits Intestinal Colonization by {beta}-Lactam-Resistant Klebsiella pneumoniae in Cefotaxime-Treated Mice
- Are Observational Studies More Informative Than Randomized Controlled Trials in Hypertension?: Con Side of the Argument
- Tuberculosis: are we making it incurable?
- IDEAL framework for surgical innovation 1: the idea and development stages
- Aminoglycoside Cross-Resistance in Mycobacterium tuberculosis Due to Mutations in the 5' Untranslated Region of whiB7
- The perilous state of independent randomized clinical trials and related applied research in Canada
- Methods in Comparative Effectiveness Research
- Worth Adapting? Revisiting the Usefulness of Outcome-Adaptive Randomization
- Randomized Trials in Surgery: How Far Have We Come?
- The Ongoing Quality Improvement Journey: Next Stop, High Reliability
- Adaptive Clinical Trials: The Promise and the Caution
- How long should treatments be continued?
- The Birth of the Subspecialty of Medical Oncology and Examples of Its Early Scientific Foundations
- Comparative Effectiveness Research: What Kind of Studies Do We Need?
- CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
- What kind of randomized trials do we need?
- Managing drug resistant tuberculosis
- Randomized Clinical Trials and Observational Studies: Guidelines for Assessing Respective Strengths and Limitations
- Tuberculosis: evolution in millennia and minutes
- Tuberculosis drug resistance in Europe: sunny days, but clouds on the horizon?
- Clinical Trials in Cardiovascular Medicine in an Era of Marginal Benefit, Bias, and Hyperbole
- Imipenem for Treatment of Tuberculosis in Mice and Humans
- Treatment at Random: The Ultimate Science or the Betrayal of Hippocrates?
- Combined-Modality Therapy of Locally Advanced Cervical Cancer
- Reviewer diligence
- Clinical trials in orthodontics I: demographic details of clinical trials published in three orthodontic journals between 1989 and 1998
- Casting and drawing lots: a time honoured way of dealing with uncertainty and ensuring fairness
- Statistics Notes: Concealing treatment allocation in randomised trials
- Statistics notes: Treatment allocation in controlled trials: why randomise?
- Unbiased, relevant, and reliable assessments in health care
- Use of randomisation in the Medical Research Council's clinical trial of streptomycin in pulmonary tuberculosis in the 1940s
- Doing Harm: The DES Tragedy and Modern American Medicine
- Old problems, new challenges